Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.
Quick Stats
Jan 30, 202656.0
AI Score
HOLD1.06
Volume Ratio
Feb 26, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
NUVL Stock Summary
Last updated Jan 30, 2026
NUVL is currently trading at $102.89, positioned above its 200-day moving average of $86.63, indicating a long-term uptrend. The stock has a 52-week range of $55.535 to $113.015.
Technical Analysis: The 50-day moving average stands at $104.85, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 48.172, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.006, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NUVL at 56.0/100 with a HOLD recommendation.
NUVL (Nuvalent, Inc. Class A Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 48.172 |
| CMF (20) | -0.006 |
| ROC (10) | -3.08 |
| ADX (14) | 13.725 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.271 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -64.945 |
| MFI (14) | 45.09 |
NUVL Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NUVL Price vs Max Options Open Interest
NUVL Max Change In Options Open Interest
NUVL Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NUVL Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NUVL Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NUVL Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Nuvalent, Inc. Class A Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
NUVL Moving Averages Analysis
Nuvalent, Inc. Class A Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
NUVL (Nuvalent, Inc. Class A Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 105.62 |
| 20 | 104.06 |
| 30 | 103.69 |
| 50 | 104.85 |
| 100 | 96.72 |
| 200 | 86.63 |
NUVL Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 7.4 billion |
| Earnings/Share ($) | -5.33 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -5.4984 |
| EPS Estimate Next Year ($) | -5.6031 |
| WallStreet Target Price ($) | 141.7059 |
| Most Recent Quarter |